The impact of COVID-19 on rheumatology practice across Africa

Richard O Akintayo1, Akpabio A Akpabio2, Asgar A Kalla3

  • 1Rheumatology Department, Dumfries and Galloway Royal Infirmary, Dumfries, UK.

Insights

The COVID-19 pandemic significantly altered rheumatology care in Africa, increasing virtual consultations. Regional disparities in protocols and registries became more evident, impacting service delivery.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presented unprecedented challenges to healthcare systems globally.
  • Rheumatology services in Africa faced disruptions, necessitating adaptation in care delivery models.

Purpose of the Study:

  • To assess the impact of the COVID-19 pandemic on rheumatology service delivery across Africa's five regions.
  • To identify changes in clinical practices and the adoption of new care modalities.

Main Methods:

  • An online survey was developed by the COVID-19 African Rheumatology Study Group, comprising 40 questions.
  • The survey targeted rheumatologists across Africa, adhering to the CHERRIES checklist for reporting internet e-surveys.
  • A total of 554 responses were collected from 20 countries.

Main Results:

  • Teleconsultation adoption varied, with telephone (60.5%) and WhatsApp (43.5%) being most common.
  • Face-to-face clinics continued for 52.9% of rheumatologists, often with reduced physical examinations or personal protective equipment.
  • Only 57.0% of national rheumatology societies issued COVID-19 recommendations, and 13.2% had a national registry.

Conclusions:

  • The COVID-19 pandemic accelerated the shift towards virtual rheumatology consultations in Africa.
  • Significant regional disparities exist in the availability of local protocols and COVID-19 registries for rheumatology care.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
155
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
264
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
284
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
167
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.9K